CDER’s Cavazzoni Warns Drug Shortages Becoming More Complex

While the U.S. has seen a decrease in the number of shortages, the country has seen an increase in the complexity of shortages and the time necessary to mitigate these shortages, warns Patrizia Cavazzoni, director of the FDA’s CDER, speaking at the 2023 PDA/FDA Joint Regulatory Conference.
Source: Drug Industry Daily